# Carolyn Fritz

> Carolyn Fritz is a Series A investor at Lewis & Clark Capital backing Biotechnology. See 2 investments, round sizes, portfolio and contact details. Updated…

- Type: Angel Investor
- Firm: Lewis & Clark Capital
- Total investments: 2
- Last investment: Jun 2025
- Lead investor: 50%
- Last updated: Aug 2026
- LinkedIn: http://www.linkedin.com/pub/carolyn-fritz/0/316/62a

Carolyn Fritz is a Series A investor at Lewis & Clark Capital focused on Biotechnology and Pharmaceutical. Ms. Fritz is currently Chairman of the Board of the synthetic biology company, DMC Biotechnologies; a board member of the microfibrillated cellulose company, CelluComp Ltd. and a Strategic Advisor to the phytochemical AI company, Brightseed. Prior to this, Ms. Fritz successfully built four biotechnology businesses. From 2004 - 2014, she builtthe synthetic biology company, Allylix from a start-up, raising $34 million in VC funding, developing and commercializing flavor & fragrances and insect repellents to a successful sale of company. From 1999 to 2004, at Dow Chemical, she built a renewable epoxy coating and soy polyol business and a biopharmaceutical contract manufacturing. From 1993 to 1999, at Cargill, she built an ag biotechnology/food technology business that developed and commercialized new functional canola oils for food and industrial markets. Ms. Fritz has her M.B.A from the Wharton School, University of Pennsylvania, her M.S. from The George Washington University and her B.S. in Mechanical Engineering from Iowa State University.

## Contacts

5 contacts available for Carolyn Fritz: work email, personal email, work phone, personal phone and socials. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-email/carolyn-fritz?utm_source=investor_profile

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Biotechnology | 2 | 100% |
| Pharmaceutical | 2 | 100% |
| Biofuel | 1 | 50% |
| Medical | 1 | 50% |
| Agriculture | 1 | 50% |

## Investments

| Company | Description | Round size | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Matterworks | Matterworks is a biotech startup that combines metabolomics with AI to simulate the metabolic environment. The startup is enabling real-time insights into cellular biology to accelerate therapeutic research, development, and manufacturing with an AI-driven cloud platform for metabolomics.Matterworks was founded by Mimoun Cadosch Delmar and JackGeremia in 2019. |  | Series A | Jun 03, 2025 | https://www.matterworksbio.com/ |
| Allylix | Allylix, Inc., an early stage biotechnology company, develops terpene products and their derivatives for the flavor and fragrance, food ingredient, pharmaceutical, agricultural, and biofuel markets. Its products comprise nootkatone, which is a grapefruit flavor that is used in fruit juices and citrus flavored sodas. The company also developssesquiterpenes that are part of aroma chemical segment of the flavor and fragrance market; and production platforms for pharmaceutical, nutraceutical, and agricultural markets. Allylix, Inc. was founded in 2002 and is based in San Diego, California with research and development laboratories in Lexington, Kentucky. | $1.5M | Series A | Aug 30, 2005 | http://www.allylix.com |

2 of 2 investments shown.

## Co-investors
- [Bluegrass Angels](https://shizune.co/investors/profile/bluegrass-angels) — VC Fund, 1 deal together
- [Commonwealth Seed Capital](https://shizune.co/investors/profile/commonwealth-seed-capital) — VC Fund, 1 deal together
- [Germin8 Ventures](https://shizune.co/investors/profile/germin8-ventures) — VC Fund, 1 deal together
- [Intermountain Ventures](https://shizune.co/investors/profile/intermountain-ventures) — VC Fund, 1 deal together
- [Keyhorse Capital](https://shizune.co/investors/profile/keyhorse) — VC Fund, 1 deal together
- [Keyhorse Capital (KSTC)](https://shizune.co/investors/profile/mammothview) — VC Fund, 1 deal together

## Similar investors

### Similar industry
- [SVG Ventures](https://shizune.co/investors/profile/svg-ventures) — VC Fund
- [SOSV](https://shizune.co/investors/profile/sosv) — VC Fund
- [Omnivore](https://shizune.co/investors/profile/omnivore-partners) — VC Fund

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund

### Similar country
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund

## Featured in investor lists
- [Agriculture (agtech) Angel Investors in United States](https://shizune.co/investors/agriculture-agtech-angel-investors-united-states)

## FAQ

### What does Carolyn Fritz invest in?

Carolyn Fritz invests primarily in Biotechnology, Pharmaceutical and Biofuel startups, most often at Series A stage. Most of the 2 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### How do I contact Carolyn Fritz?

Public channels for Carolyn Fritz include LinkedIn. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### When did Carolyn Fritz last invest?

The most recent investment recorded for Carolyn Fritz closed in Jun 2025. Shizune tracks 2 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co